Adherence to National Comprehensive Cancer Network ALK Testing Guidelines for Patients with Advanced Non‐Small Cell Lung Cancer in U.S. Community Medical Centers

BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines recommend biomarker testing as the first step in the management of patients with advanced non‐small cell lung cancer (aNSCLC). We assessed anaplastic lymphoma kinase (ALK) testing rates and factors related to underuse in community m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernicker, Eric H., Xiao, Yan, Abraham, Anup, Yang, Baiyu, Croix, Denise A., Redpath, Stella, Engstrom‐Melnyk, Julia, Shah, Roma, Madala, Jaya, Allen, Timothy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Lung Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176985/
https://www.ncbi.nlm.nih.gov/pubmed/33823082
http://dx.doi.org/10.1002/onco.13779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176985/
https://www.ncbi.nlm.nih.gov/pubmed/33823082
http://dx.doi.org/10.1002/onco.13779

Ejemplares similares